When the team focused on individual countries, they found that China faces the largest economic cost of cancers at INT $6.1 trillion, followed by the United States with INT $5.3 trillion. The largest burden in both China and the US comes from tracheal, bronchus, and lung cancer. As expected, the cost is skewed toward high-income nations, despite three quarters of deaths occurring in low- and middle-income countries.
"We need to apply all we already know to address the problem if we want to make a dent on the rising economic global cost of cancer," he adds."The time is now." This study was funded by the National Institute on Aging, the National Institutes of Health, the Chinese Academy of Engineering, the Chinese Academy of Medical Sciences & Peking Union Medical College, Horizon Europe, and the Bill & Melinda Gates Foundation. The study authors report no relevant financial relationships.